Giovanna Barba Spaeth

Title: Giovanna Barba Spaeth: Innovator in Flavivirus Research

Introduction

Giovanna Barba Spaeth is a prominent inventor based in Paris, France. She has made significant contributions to the field of virology, particularly in the development of neutralizing antibodies against flaviviruses. With a total of 2 patents, her work is crucial in the prevention and treatment of infections such as Zika and dengue.

Latest Patents

Her latest patents include innovative methods for utilizing neutralizing antibodies against dengue for the prevention and treatment of Zika infection. One patent describes a flavivirus Envelope Dimer Epitope (EDE) that is a stabilized recombinant flavivirus. This dimer is covalently stabilized with disulphide inter-chain bonds or sulfhydryl-reactive crosslinkers, and it can be formed as a single polypeptide chain. The dimer can also be a homodimer or heterodimer of native and/or mutant envelope polypeptides from various flaviviruses, including DENV-1, DENV-2, DENV-3, DENV-4, and Zika.

Career Highlights

Giovanna has worked with prestigious institutions such as Institut Pasteur and Imperial College Innovations Limited. Her research has focused on the development of vaccines and therapeutic methods against flavivirus infections, showcasing her expertise in the field.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Marie-Christine Vaney and Gavin Screaton. These partnerships have further enhanced her research and contributions to the scientific community.

Conclusion

Giovanna Barba Spaeth is a leading inventor whose work in flavivirus research is paving the way for innovative treatments and vaccines. Her patents reflect her dedication to advancing medical science and improving public health.